<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04135573</url>
  </required_header>
  <id_info>
    <org_study_id>2018109</org_study_id>
    <nct_id>NCT04135573</nct_id>
  </id_info>
  <brief_title>The Relationship Between NK Cell and Graves' Disease</brief_title>
  <official_title>Mechanism of NK Cell Disfunction in Graves' Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong Provincial Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Graves' disease (GD) is one of organ specific autoimmune diseases, the pathogenesis is not&#xD;
      elucidated.Natural Killer (Natural Killer, NK) cells is a kind of important immune regulator,&#xD;
      several abnormalities of NK cell function and number in GD patients have been described in&#xD;
      the investigators' previous study. It is remain unclear whether the NK cell disfunction is a&#xD;
      consequence of GD.Based on the investigators' previous study, the investigators plan to&#xD;
      monitor NK cell function in participants in the whole course of disease, analyze the&#xD;
      association with relevant factors, such as thyroid function, immune state or treatment,to&#xD;
      find out influences of thyroid hormones and thyroid receptor antibody affecting the function&#xD;
      of NK cell. The investigators will reveal whether the disfunction of NK cell secondary to GD&#xD;
      abnormal thyroid function and/or immune disorders, and realize the mechanics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>The number and function of NK cells changes of hyperthyroidism</measure>
    <time_frame>measured after 2 years of follow-up</time_frame>
    <description>Flow cytometry used to measure the related changes of NK cells in hyperthyroidism</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in serum levels</measure>
    <time_frame>measured after 2 years of follow-up</time_frame>
    <description>Detection of related cytokines by ELISA</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Graves Disease</condition>
  <arm_group>
    <arm_group_label>New untreated GD patients</arm_group_label>
    <description>Before treatment and application of anti-thyroid drugs (methimazole) or radioactive iodine treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <description>No thyroid related diseases and other immune diseases</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serumï¼Œwhole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adults aged of 18 to 75 years old&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  New GD patients without any treatment&#xD;
&#xD;
          -  Aged of 18 to 75 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or lactating woman;&#xD;
&#xD;
          -  Known autoimmune disease;&#xD;
&#xD;
          -  Receiving psychotropic or hormonal drugs;&#xD;
&#xD;
          -  Taking drugs that affect the body's immune function;&#xD;
&#xD;
          -  Obviously poor compliance.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haiqing Zhang</last_name>
    <role>Study Chair</role>
    <affiliation>Shandong Provincial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shandong Provincial Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2019</study_first_posted>
  <last_update_submitted>April 12, 2021</last_update_submitted>
  <last_update_submitted_qc>April 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong Provincial Hospital</investigator_affiliation>
    <investigator_full_name>Hai-qing Zhang</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Atuoimmune thyroid disease</keyword>
  <keyword>Graves' disease</keyword>
  <keyword>Natural killer cell</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graves Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

